Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcomeric genotyping in hypertrophic cardiomyopathy.

Sara L Van Driest1, Steve R Ommen, A Jamil Tajik

  • 1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|April 12, 2005
PubMed
Summary

Genetic variations in hypertrophic cardiomyopathy (HCM) do not clearly predict patient phenotypes. Further research is needed to understand how genetic and environmental factors influence HCM presentation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac amyloidosis with apical myocardial infarction: beyond the cherry on top.

ESC heart failure·2026
Same author

Clinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis.

American heart journal plus : cardiology research and practice·2026
Same author

Malignant Mitral Valve Prolapse With Life-Threatening Ventricular Arrhythmias: A Multidisciplinary Team-Guided Stepwise Management.

JACC. Case reports·2026
Same author

Auricular nodule in 53-year-old man with subclinical coronary artery disease.

The American journal of medicine·2026
Same author

Standing Valsalva Maneuver Accentuates Labile Obstruction in Hypertrophic Cardiomyopathy.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Flow Gradients in Severe Aortic Stenosis and Preserved Ejection Fraction: A 10-Year Transcatheter Aortic Valve Replacement Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
  • Understanding genotype-phenotype correlations is crucial for patient management.

Purpose of the Study:

  • To investigate phenotypic differences among hypertrophic cardiomyopathy (HCM) genotypes by pooling international study data.
  • To identify potential genotype-specific clinical presentations in HCM patients.

Main Methods:

  • A meta-analysis of published genotyping studies from November 1998 to November 2004.
  • Comparison of mutation frequencies, age at diagnosis, and left ventricular wall thickness across different study populations and genotypes.
  • Statistical analysis to pool and compare data.

Main Results:

Related Experiment Videos

  • The myosin binding protein C (MYBPC3) gene was the most frequent cause of HCM across all populations.
  • Mutation frequency varied by geographic origin, with the French population showing the highest rate (61%).
  • No significant differences in left ventricular wall thickness or age at diagnosis were observed across genotypes.

Conclusions:

  • Current phenotypic data are insufficient to differentiate between sarcomeric genotypes in HCM.
  • Genetic and environmental modifiers likely play a significant role in determining individual HCM phenotypes.
  • Further investigation into these modifiers is warranted.